Back to top

Achieve Life Sciences CRL from FDA cites deficiencies at manufacturing facility

Achieve Life Sciences (ACHV) announced that it has received a complete response letter, or CRL, from the FDA regarding the new drug application, or...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Achieve Life Sciences, Inc. (ACHV)